![Bruce Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruce Carter
Président chez
ENANTA PHARMACEUTICALS, INC.
Fortune : - $ au 30/06/2026
Profil
Bruce Leonard Andrews Carter is Non-Executive Chairman at Enanta Pharmaceuticals, Inc. since 2015, Chairman at ALSP Orchid Acquisition Corp.
I, Director at Dr. Reddy's Laboratories, Inc., Independent Director at Aurigene Oncology Ltd., Professor at the University of Washington since 1986, and Senior Advisor at Accelerator Services Corp.
Former roles include Chairman at ZymoGenetics, Inc. from 2009 to 2010, Executive Chairman at Global Alliance for TB Drug Development in 2013, Chairman at Xencor, Inc. from 2009 to 2017, Executive Chairman at Immune Design Corp.
from 2009 to 2011, Executive Chairman at Infectious Disease Research Institute in 2011, Chairman at Infectious Disease Research Institute, Independent Director at QLT, Inc. from 2006 to 2012, Independent Non-Executive Director at Dr. Reddy's Laboratories Ltd. from 2008 to 2022, Director at Renovis, Inc. from 2005 to 2008, Independent Director at Mirati Therapeutics, Inc. from 2016 to 2024, Independent Director at Regulus Therapeutics, Inc. from 2012 to 2015, Director at Immune Design Corp.
from 2000 to 2009, Chief Scientific Officer & Executive VP at Novo Nordisk A from 1994 to 1998, and Head-Molecular Genetics at G.D.
Searle & Co., Inc. from 1982 to 1986.
Education includes a doctorate from Queen Elizabeth College and an undergraduate degree from The University of Nottingham.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Bruce Carter
| Sociétés | Poste | Début |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Président | 14/12/2015 |
| ALSP ORCHID ACQUISITION CORPORATION I | Président | - |
Dr. Reddy's Laboratories, Inc.
 Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops pharmaceuticals products | Directeur/Membre du Conseil | - |
Aurigene Oncology Ltd.
 Aurigene Oncology Ltd. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Directeur/Membre du Conseil | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1986 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de Bruce Carter
| Sociétés | Poste | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Directeur/Membre du Conseil | 23/01/2024 |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Président | 23/02/2023 |
| DR. REDDY'S LABORATORIES LIMITED | Directeur/Membre du Conseil | 30/07/2022 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Bruce Carter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Dr. Reddy's Laboratories Ltd.
 Dr. Reddy's Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
McAdams Wright Ragen, Inc.
 McAdams Wright Ragen, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Moksha8 Pharmaceuticals, Inc.
 Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
Queen Elizabeth College
 Queen Elizabeth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Commercial Services |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Dr. Reddy's Laboratories, Inc.
Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops pharmaceuticals products | Health Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Commercial Services |
Aurigene Oncology Ltd.
Aurigene Oncology Ltd. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Health Technology |
Navigating Cancer, Inc.
 Navigating Cancer, Inc. Internet Software/ServicesTechnology Services Operates as a patient engagement and care management platform | Technology Services |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
Choisissez Zonebourse 
